Dave King, JD
Dave joined HealthQuest in 2023 as an Operating Partner focused on the Tactical Opportunities Fund, and has been a HealthQuest advisory board member since the inception of the firm. Dave also serves as Executive Chairman for HealthQuest Portfolio company, ScribeAmerica. Most recently, Dave was executive chairman and CEO of LabCorp (NYSE: LH). Dave is a respected senior healthcare leader who operates with a strong emphasis on deeply understanding the healthcare industry, strategic planning, “playing the long game,” and staying ahead of rapidly evolving industry trends and challenges. Under his leadership, LabCorp transformed from a pure-play U.S. testing laboratory into a leading global life sciences company — tripling in size through a combination of organic growth and strategic acquisitions, entering the Fortune 500, and being named to Fortune’s List of World’s Most Admired Companies. It is now the world’s largest clinical laboratory and second-largest drug development business.
Dave is the non-executive chairman of Privia Health (NASDAQ: PRVA) and serves on the boards of ZimVie (NASDAQ: ZIMV) and VaxCare. Dave’s extensive commitment to community service includes prior and current roles: serving as board chair of PATH, a nonprofit global health organization; board member of Novant Health, a multi-state integrated health system; member of the advisory board and executive committee of Duke University’s Robert J. Margolis, MD, Center for Health Policy; and board member of The Emily K Center, a college-readiness center founded by Duke coach Mike Krzyzewski. Dave previously served on the board of Cardinal Health (NYSE: CAH), a Fortune 20 healthcare company, and the American Clinical Laboratory Association, where he served as board chair from 2010 to 2014. Dave holds a bachelor’s degree, cum laude, from Princeton University and a Juris Doctor, cum laude, from the University of Pennsylvania Law School.
